ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04919	Thyroid hormone signaling pathway	4/23	143/7206	0.000981722414784
ko05161	Hepatitis B	4/23	173/7206	0.00198799720107
ko05220	Chronic myeloid leukemia	3/23	85/7206	0.00236563979672
ko04350	TGF-beta signaling pathway	3/23	103/7206	0.00408022624705
ko04520	Adherens junction	3/23	103/7206	0.00408022624705
ko05215	Prostate cancer	3/23	111/7206	0.00503327382089
ko04066	HIF-1 signaling pathway	3/23	123/7206	0.00669788328185
ko04120	Ubiquitin mediated proteolysis	3/23	138/7206	0.00919405823489
ko05166	HTLV-I infection	4/23	292/7206	0.0127144394194
ko05164	Influenza A	3/23	167/7206	0.015401654353
ko04068	FoxO signaling pathway	3/23	167/7206	0.015401654353
ko04330	Notch signaling pathway	2/23	62/7206	0.0164073783629
ko05200	Pathways in cancer	5/23	492/7206	0.017513404202
ko05168	Herpes simplex infection	3/23	182/7206	0.0193548815777
ko05152	Tuberculosis	3/23	187/7206	0.0207873748683
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/23	191/7206	0.0219749161166
ko00310	Lysine degradation	2/23	73/7206	0.0223237991381
ko05169	Epstein-Barr virus infection	3/23	206/7206	0.0267581128032
ko05212	Pancreatic cancer	2/23	83/7206	0.0283563393345
ko05211	Renal cell carcinoma	2/23	96/7206	0.0370605434894
ko05132	Salmonella infection	2/23	98/7206	0.0384812220814
ko04720	Long-term potentiation	2/23	99/7206	0.039199413262
ko04659	Th17 cell differentiation	2/23	106/7206	0.0443698505101